Price sits below both the 50- and 200-day moving averages. Rallies in this configuration tend to be sold; the burden of proof is on the bulls.
JSE ticker · ISO
ASP ISOTOPES INC. (ISO) Share Price & Latest SENS Announcements
ASP Isotopes Inc.
Track ASP Isotopes Inc. (ISO) share price moves, recent SENS announcements, company profile details, and Basic Materials sector, specialty chemicals, all in one place.
Latest SENS Announcements — ASP ISOTOPES INC. (ISO)
10 most recent- 26 Oct Other Administrative
ASP ISOTOPES INC - Form 8-K current report
ASP Isotopes tells JSE holders a Form 8-K was filed with the SEC, without stating its contents.
NEUTRAL 0 - 26 Oct Operational Update
ASP ISOTOPES INC - ASP Isotopes Inc. announces that Renergen Limiteds Virginia Gas Project has achieved stable liquid helium production
Tetra4 achieves stable liquid helium production at Virginia Gas Project, with first deliveries still pending.
BULLISH +38 - 22 Oct Director Dealings
ASP ISOTOPES INC - Form 4 statement of changes in beneficial ownership
ASP Isotopes files a Form 4 with the SEC; the SENS notice links to it but does not state the transaction terms.
NEUTRAL 0 - 19 Oct Director Dealings
ASP ISOTOPES INC - Form 4 statement of changes in beneficial ownership
ASP Isotopes filed an SEC Form 4 on 16 October, but the SENS notice discloses no transaction details.
NEUTRAL 0 - 19 Oct Director Dealings
ASP ISOTOPES INC - Form 144 report of proposed sale of securities
ASP Isotopes flags a Form 144 proposed sale; the seller, size, value and timing are in the linked Form 144.
NEUTRAL 0 - 15 Oct Other Administrative
ASP ISOTOPES INC - Form 8-K current report
ASPI files a Form 8-K; this SENS notice forwards the notification without disclosing what the SEC filing contains.
NEUTRAL 0 - 15 Oct Acquisition
ASP ISOTOPES INC - Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa
QLE signs binding 80/20 HALEU JV framework with Necsa, but no deal value or funding plan is disclosed.
NEUTRAL -5 - 15 Oct Director Dealings
ASP ISOTOPES INC - Form 144 report of proposed sale of securities
ASPI files a Form 144 flagging a proposed securities sale, with no seller, size, price or timing disclosed.
NEUTRAL 0 - 09 Oct Other Administrative
ASP ISOTOPES INC - Form 8-K Current Report and Rule 425 Written Communication Related to a Business Combination
SENS notifies investors that SEC beneficial-ownership filings (Schedule 13D and Form 3) were made.
NEUTRAL 0 - 02 Oct Other Administrative
ASP ISOTOPES INC - Form 8-K current report
ASPI notifies shareholders it filed a Form 8-K referencing ENDRA Life Sciences' S-4; no transaction terms disclosed.
NEUTRAL 0
Price · Close
- Trend
- Down · below 50 & 200
- Momentum
- Down
- RSI 14
- 30
- 30D Vol
- 84.3%
What Changed
Delta viewLatest SENS 1h ago: "ASP ISOTOPES INC - Form 8-K current report" — reading mixed.
Market
Valuation
Technicals
Annualised · 30 sessionsAnalyst ratings & fundamentals for ASP ISOTOPES INC. aren't available yet.
Why It Matters
Combined viewASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.
- Exchange
- Johannesburg
- Currency
- ZAc
- Employees
- 271
- Country
- United States
- Website
- https://aspisotopes.com
Build your JSE watchlist.
Save tickers, follow new SENS announcements, and get personalised daily analysis.
→ Create Free Account